These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 21637178)

  • 1. Pathologizing old age: the case of osteoporosis.
    Grob GN
    MD Advis; 2011; 4(2):20-2, 24-7. PubMed ID: 21637178
    [No Abstract]   [Full Text] [Related]  

  • 2. [Calcium pros and cons: long term use of bisphosphonates. Bisphosphonates should be used for postmenopausal osteoporosis for a long term].
    Soen S
    Clin Calcium; 2011 Oct; 21(10):1543-6. PubMed ID: 21960242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A once-yearly IV bisphosphonate for osteoporosis.
    Med Lett Drugs Ther; 2007 Nov; 49(1273):89-90. PubMed ID: 17975523
    [No Abstract]   [Full Text] [Related]  

  • 4. Characterization of patients with an inadequate clinical outcome from osteoporosis therapy: the Observational Study of Severe Osteoporosis (OSSO).
    Jakob F; Marín F; Martín-Mola E; Torgerson D; Fardellone P; Adami S; Thalassinos NC; Sykes D; Melo-Gomes J; Chinn C; Nicholson T; Cooper C
    QJM; 2006 Aug; 99(8):531-43. PubMed ID: 16861718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lasofoxifene: new drug. Osteoporosis: no better than raloxifene.
    Prescrire Int; 2009 Dec; 18(104):247. PubMed ID: 20020572
    [No Abstract]   [Full Text] [Related]  

  • 6. [Osteoporosis and bisphosphonates].
    Zuber MA
    Z Rheumatol; 2007 Dec; 66(8):713-5. PubMed ID: 17955251
    [No Abstract]   [Full Text] [Related]  

  • 7. [Osteoporosis].
    Pfeilschifter J
    MMW Fortschr Med; 2004 Mar; 146(11):61, 63. PubMed ID: 15152780
    [No Abstract]   [Full Text] [Related]  

  • 8. [FACT study].
    Tanaka I; Oshima H
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():280-5. PubMed ID: 18161120
    [No Abstract]   [Full Text] [Related]  

  • 9. Annual zoledronic acid for osteoporosis.
    BMJ Group
    Drug Ther Bull; 2008 Dec; 46(12):93-6. PubMed ID: 19056701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment holidays in patients with postmenopausal osteoporosis: whom and when?
    Reyes García R; García Martín A; Muñoz-Torres M
    Endocrinol Nutr; 2012 Dec; 59(10):573-4. PubMed ID: 23031434
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prevention of osteoporotic fractures].
    Kannus P
    Duodecim; 1999; 115(7):759-64. PubMed ID: 11859509
    [No Abstract]   [Full Text] [Related]  

  • 12. Estimating the effects of time-varying treatments: incidence of fractures among postmenopausal Japanese women.
    Tanaka S; Matsuyama Y; Shiraki M; Ohashi Y
    Epidemiology; 2007 Sep; 18(5):529-36. PubMed ID: 17700241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of osteoporosis in older persons.
    Zarowitz BJ
    Geriatr Nurs; 2006; 27(1):16-8. PubMed ID: 16483895
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of a decision aid to improve treatment decisions in osteoporosis: the osteoporosis choice randomized trial.
    Montori VM; Shah ND; Pencille LJ; Branda ME; Van Houten HK; Swiglo BA; Kesman RL; Tulledge-Scheitel SM; Jaeger TM; Johnson RE; Bartel GA; Melton LJ; Wermers RA
    Am J Med; 2011 Jun; 124(6):549-56. PubMed ID: 21605732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zoledronic acid: new indication. No therapeutic advantage in postmenopausal osteoporosis.
    Prescrire Int; 2008 Aug; 17(96):143. PubMed ID: 19480098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteodensitometry in healthy postmenopausal women.
    Prescrire Int; 2008 Apr; 17(94):68-72. PubMed ID: 18536138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis.
    Iwamoto J; Takeda T; Sato Y
    Curr Med Res Opin; 2006 May; 22(5):919-28. PubMed ID: 16709313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postmenopausal osteoporosis: another approach to management.
    Cole R
    J Fam Pract; 2010 Jun; 59(6):E1-7. PubMed ID: 20544058
    [No Abstract]   [Full Text] [Related]  

  • 19. Ibandronic acid IV: new formulation. Unconvincing evidence.
    Prescrire Int; 2008 Feb; 17(93):10. PubMed ID: 18354845
    [No Abstract]   [Full Text] [Related]  

  • 20. Assessment of the relationship between age and the effect of risedronate treatment in women with postmenopausal osteoporosis: a pooled analysis of four studies.
    Boonen S; Klemes AB; Zhou X; Lindsay R
    J Am Geriatr Soc; 2010 Apr; 58(4):658-63. PubMed ID: 20345865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.